ConductScience.org, home

Paper8872500

Effect of recombinant human interleukin 2 on neutrophil adherence to endothelial cells in vitro.

Li J and 3 others. Inflammation, 1996. Cited by 31 papers, by iCite.

Cite this record

ConductScience Library. Effect of recombinant human interleukin 2 on neutrophil adherence to endothelial cells in vitro. Papers, record 8872500. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8872500

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of recombinant human interleukin 2 on neutrophil adherence to endothelial cells in vitro.
PubMed
Journal
Inflammation
PubMed
Year
1996
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
31
iCite
Relative citation ratio, by iCite
0.69
iCite
Revised in PubMed
2019-09-20
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li JJ
2Gyorffy SS
3Lee SS
4Kwok CSC S

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Endothelium, VascularMajor topic
Interleukin-2Major topic
NeutrophilsMajor topic
Adult
CD18 Antigens
Capillary Leak Syndrome
Cell Adhesion
Cell Adhesion Molecules
Cells, Cultured
Humans
N-Formylmethionine Leucyl-Phenylalanine
Receptors, Interleukin-2
Recombinant Proteins
Umbilical Veins

Source PubMed

Download CSV of topics

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18436829Activation of tumor necrosis factor-alpha production from human neutrophils by IL-2 via IL-2-R beta.J Immunol1993https://conductscience.org/library/papers/8436829PubMed
28112867Alterations of neutrophil responses to tumor necrosis factor alpha and interleukin-8 following human endotoxemia.Infect Immun1994https://conductscience.org/library/papers/8112867PubMed
33143745Influence of natural and recombinant interleukin 2 on endothelial cell arachidonate metabolism. Induction of de novo synthesis of prostaglandin H synthase.J Clin Invest1988https://conductscience.org/library/papers/3143745PubMed
43258138Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial.Ann Intern Med1988https://conductscience.org/library/papers/3258138PubMed
57981154Expression of the IL-2 receptor gamma chain on various populations in human peripheral blood.Int Immunol1994https://conductscience.org/library/papers/7981154PubMed
61917149The systemic complement activation caused by interleukin-2/lymphokine-activated killer-cell therapy of cancer causes minimal systemic neutrophil activation.Int J Cancer1991https://conductscience.org/library/papers/1917149PubMed
71549576
The interleukin 2 receptor (IL-2R): the IL-2R alpha subunit alters the function of the IL-2R beta subunit to enhance IL-2 binding and signaling by mechanisms that do not require binding of IL-2 to IL-2R alpha subunit.
Proc Natl Acad Sci U S A1992https://conductscience.org/library/papers/1549576PubMed
88054514Interleukin-2 (IL-2) activated natural killer (A-NK) cells: binding to microvascular endothelial cells and BRM enhancement of cytolytic activity.In Vivo1994https://conductscience.org/library/papers/8054514PubMed
93262010Mechanism of cultured endothelial injury induced by lymphokine-activated killer cells.Cancer Res1988https://conductscience.org/library/papers/3262010PubMed
103711336Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates.J Clin Invest1986https://conductscience.org/library/papers/3711336PubMed
117919341
Pentoxifylline inhibits integrin-mediated adherence of interleukin-2- activated human peripheral blood lymphocytes to human umbilical vein endothelial cells, matrix components, and cultured tumor cells.
Blood1994https://conductscience.org/library/papers/7919341PubMed
123493433Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer.N Engl J Med1987https://conductscience.org/library/papers/3493433PubMed
131596901Interleukin 2 acutely induces platelet and neutrophil-endothelial adherence and macromolecular leakage.Cancer Res1992https://conductscience.org/library/papers/1596901PubMed
148380826Function associated with IL-2 receptor-beta on human neutrophils. Mechanism of activation of antifungal activity against Candida albicans by IL-2.J Immunol1993https://conductscience.org/library/papers/8380826PubMed
151733448The activation of polymorphonuclear neutrophils and the complement system during immunotherapy with recombinant interleukin-2.Br J Cancer1992https://conductscience.org/library/papers/1733448PubMed
167861762Tumor necrosis factor-alpha and interleukin-6 selectively regulate neutrophil function in vitro.J Surg Res1995https://conductscience.org/library/papers/7861762PubMed
178026467Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15.EMBO J1994https://conductscience.org/library/papers/8026467PubMed
183279124Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome.J Immunol1988https://conductscience.org/library/papers/3279124PubMed
197882594Role of TNF alpha, IL-1, and IL-1ra in the mediation of leukocyte infiltration and increased vascular permeability in rabbits with LPS-induced pleurisy.Clin Immunol Immunopathol1995https://conductscience.org/library/papers/7882594PubMed
203262487Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock.Chest1988https://conductscience.org/library/papers/3262487PubMed

See all 30 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.

PMIDTitleJournalYearIn PapersSource
42732002Orphan GPR84 facilitates uropod de-adhesion at multiple steps during leukocyte extravasation.EMBO Rep2026https://conductscience.org/library/papers/42732002PubMed
41353412An immune competent in vitro model of IL2 induced vascular leakage enables mechanistic insights and evaluation of mitigation strategies.Sci Rep2025https://conductscience.org/library/papers/41353412PubMed
40811745Immune cells play a critical role in cytokine- and endotoxin-mediated endothelial permeability.PLoS One2025https://conductscience.org/library/papers/40811745PubMed
39370477Breaking a dogma: orthodontic tooth movement alters systemic immunity.Prog Orthod2024https://conductscience.org/library/papers/39370477PubMed
38967887Association of serum interleukin-2 with severity and prognosis in hospitalized patients with community-acquired pneumonia: a prospective cohort study.Intern Emerg Med2024https://conductscience.org/library/papers/38967887PubMed
38474145Human Macrophages Activate Bystander Neutrophils' Metabolism and Effector Functions When Challenged with Mycobacterium tuberculosis.Int J Mol Sci2024https://conductscience.org/library/papers/38474145PubMed
38087370Targeting the myeloid microenvironment in neuroblastoma.J Exp Clin Cancer Res2023https://conductscience.org/library/papers/38087370PubMed
34734110Engineering Strategies for Immunomodulatory Cytokine Therapies - Challenges and Clinical Progress.Adv Ther (Weinh)2021https://conductscience.org/library/papers/34734110PubMed
33105656The Neutrophil: The Underdog That Packs a Punch in the Fight against Cancer.Int J Mol Sci2020https://conductscience.org/library/papers/33105656PubMed
25083614A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes.Transplantation2015https://conductscience.org/library/papers/25083614PubMed
24127752On-chip evaluation of neutrophil activation and neutrophil-endothelial cell interaction during neutrophil chemotaxis.Anal Chem2013https://conductscience.org/library/papers/24127752PubMed
22816782Neutrophil chemotaxis within a competing gradient of chemoattractants.Anal Chem2012https://conductscience.org/library/papers/22816782PubMed
21606942Interleukin-2 is present in human blood vessels and released in biologically active form by heparanase.Immunol Cell Biol2012https://conductscience.org/library/papers/21606942PubMed
15685449Local interleukin 2 therapy is most effective against cancer when injected intratumourally.Cancer Immunol Immunother2005https://conductscience.org/library/papers/15685449PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
IL2RA3559PubTator's text mininghttps://conductscience.org/library/genes/3559NCBI Gene
IL2RB3560PubTator's text mininghttps://conductscience.org/library/genes/3560NCBI Gene
ITGB23689PubTator's text mininghttps://conductscience.org/library/genes/3689NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8872500

GET https://conductscience.org/api/papers/v1/8872500/references?page=2